"Methodist Jennie Edmundson Hospital was established in 1886 and became a Methodist Health System affiliate in 1994. Today it is a 230-bed regional health care center serving approximately 250,000 residents in western Iowa. Jennie Edmundson employs a workforce of over 400 full-time and over 160 part-time employees, and it has an active medical staff of nearly 170 physicians. It boasts western Iowa's only accredited cancer program. The hospital offers a 24/7 Level III Emergency Department that treats over 20,000 patients per year. Jennie Edmundson also performs over 7,000 inpatient and outpatient surgeries per year while surpassing over 500 births yearly."

During the past decade, Jennie Edmundson Memorial Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jennie Edmundson Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "University of Nebraska" with 2 trials sponsored and "Melinta Therapeutics, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jennie Edmundson Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Jennie Edmundson Memorial Hospital" are "Breast Cancer" (3 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials), "Melanoma" (2 trials) and "Recurrent Colon Carcinoma" (2 trials). Many other conditions were trialed in "Jennie Edmundson Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Jennie Edmundson Memorial Hospital" are "Drug" (18 trials), "Other" (13 trials), "Procedure" (11 trials), "Biological" (9 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (8 trials), "Computed Tomography" (7 trials), "Quality-of-Life Assessment" (6 trials), "Questionnaire Administration" (6 trials) and "Laboratory Biomarker Analysis" (5 trials). Other intervention names were less common.

The vast majority of trials in "Jennie Edmundson Memorial Hospital" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Jennie Edmundson Memorial Hospital". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Jennie Edmundson Memorial Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jennie Edmundson Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".